Table 1.
Comparison of clinical characters at admission in recovered COVID-19 patients with different CMR models.
|
Dysfunction of LV deformation |
Right ventricle systolic dysfunction |
|||||
|---|---|---|---|---|---|---|
| with(n = 16) | Without (n = 18) | P | with(n = 5) | without(n = 29) | P | |
| Age | 60(49.5,64.5) | 41(34,49) | 0.021 | 34(33.5,43) | 49(38,62) | 0.079 |
| Disease course | 23(16,44.3) | 19(15,28) | 0.226 | 27(19,35) | 19(15,28.5) | 0.273 |
| Severe or critically severe type | 2(12.5%) | 4(22.22%) | 0.672 | 2(40.00%) | 4(13.79%) | 0.205 |
| CT score | 5(3,5) | 3(1,5) | 0.091 | 5(1,9) | 4(2,5) | 0.710 |
| Elevated hs-CRP | 13(81.25%) | 9(50.00%) | 0.152 | 5(100%) | 17(58.62%) | 0.137 |
| Elevated LDH | 6(37.5%) | 1(5.56%) | 0.035 | 3(60.00%) | 4(13.79%) | 0.048 |
| Elevated CK | 4(25.00%) | 0 | 0.039 | 1(20.00%) | 3(10.34%) | 0.488 |
| Elevated K-MB | 1(6.25%) | 0 | 0.471 | 0 | 1(3.45%) | 1.000 |
| Elevated NT-HSST | 1(6.25%) | 0 | 0.471 | 0 | 1(3.45%) | 1.000 |
| Elevated Myoglobin | 1(6.25%) | 0 | 0.471 | 0 | 1(3.45%) | 1.000 |
| Echocardiographic abnormalities | 13(81.25%) | 7(38.89%) | 0.017 | 1(20.00%) | 19(65.52%) | 0.135 |
| Electrocardiographic abnormalities | 2(12.50%) | 1(5.56%) | 0.591 | 0 | 3(10.34%) | 1.000 |
| Cardiac abnormalities | 15(93.75%) | 8(44.44%) | 0.003 | 3(60.00%) | 20(68.97%) | 1.000 |
| Cardiac dysfunction | Myocardial edema | |||||
| with(n = 19) | without(n = 15) | p | with(n = 10) | without(n = 24) | P | |
| Age | 55(34,63.0) | 45(34,49) | 0.159 | 40.5(33,60) | 49(35.5,62) | 0.710 |
| Disease course | 23(16,42) | 18(15,23) | 0.187 | 21.5(15.8,31.5) | 19(15,30) | 0.953 |
| Severe or critically severe type | 3(15.79%) | 3(20.00%) | 1.000 | 4(40.00%) | 2(8.33%) | 0.048 |
| CT score | 5(3,5) | 3(1,5) | 0.223 | 3.5(1.0,8.5) | 4.5(2,5) | 0.647 |
| Elevated hs-CRP | 16(84.21%) | 6(40.00 %) | 0.012 | 7(70.00%) | 15(62.50%) | 1.000 |
| Elevated LDH | 7(36.84%) | 0 | 0.011 | 3(30.00%) | 4(16.67%) | 0.394 |
| Elevated CK | 4(21.05%) | 0 | 0.113 | 2(20.00%) | 2(8.33%) | 0.564 |
| Elevated CK-MB | 1(5.26%) | 0 | 1.000 | 0 | 1(4.17%) | 1.000 |
| Elevated NT-HSST | 1(5.26%) | 0 | 1.000 | 0 | 1(4.17%) | 1.000 |
| Elevated myoglobin | 1(5.26%) | 0 | 1.000 | 0 | 1(4.17%) | 1.000 |
| Echocardiographic abnormalities | 13(68.42%) | 7(46.67%) | 0.296 | 6(60.00%) | 14(58.33%) | 0.462 |
| Electrocardiographic abnormalities | 2(10.53%) | 1(6.25%) | 1.000 | 0 | 3(12.50%) | 0.549 |
| Cardiac abnormalities | 16(84.21%) | 7(46.67%) | 0.030 | 7(70.00%) | 16(66.67%) | 1.000 |
| CMR abnormality | Abbreviations: as shown in Table 1 | |||||
| with(n = 22) | without(n = 12) | P | ||||
| Age | 52.5(34,62.3) | 48(35.5,57.3) | 0.588 | |||
| Disease course | 21.5(15,31.5) | 19(15.3,29) | 0.665 | |||
| Severe or critically severe type | 4(18.18%) | 2(16.67%) | 1.000 | |||
| CT score | 4.5(2.8,5.0) | 3(1.3,5) | 0.398 | |||
| Elevated hs-CRP | 16(72.73%) | 6(50.00%) | 0.265 | |||
| Elevated LDH | 7(31.82%) | 0 | 0.036 | |||
| Elevated CK | 4(18.18%) | 0 | 0.273 | |||
| Elevated CK-MB | 1(4.55%) | 0 | 1.000 | |||
| Elevated TNT-HSST | 1(4.55%) | 0 | 1.000 | |||
| Elevated Myoglobin | 1(4.55%) | 0 | 1.000 | |||
| Echocardiographic abnormalities | 15(68.18%) | 5(46.15%) | 0.163 | |||
| Electrocardiographic abnormalities | 2(9.09%) | 1(8.33%) | 1.000 | |||
| Cardiac abnormalities | 17(80.95%) | 6(41.67%) | 0.060 | |||